Biomea Fusion, Inc.
Nasdaq · CIK 0001840439 · Fiscal year end 1231
Latest reported period: Latest published period
Operating Income
$-12.8M
Net Income
$-12.4M
Eps Basic
-0.17
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-12.8M | - | - |
| Net Income | $-12.4M | - | - |
| Eps Basic | -0.17 | - | - |
| Eps Diluted | -0.17 | - | - |
| Cash And Equivalents | $44.7M | - | - |
| Total Assets | $46.4M | - | - |
| Total Liabilities | $27.7M | - | - |
| Shareholders Equity | $18.7M | - | - |
| Operating Cash Flow | $-11.7M | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Biomea Fusion, Inc. | 2026-05-11 | 0001193125-26-217074 |
| 10-K | Biomea Fusion, Inc. | 2026-03-24 | 0001193125-26-121825 |
| 4 | Biomea Fusion, Inc. | 2025-12-15 | 0001193125-25-319222 |
| 4 | Biomea Fusion, Inc. | 2025-12-04 | 0001193125-25-308091 |
| 4 | Biomea Fusion, Inc. | 2025-12-02 | 0001193125-25-305287 |
| 10-Q | Biomea Fusion, Inc. | 2025-11-04 | 0001193125-25-264679 |
| 4 | Biomea Fusion, Inc. | 2025-08-13 | 0000950170-25-108041 |
| 10-Q | Biomea Fusion, Inc. | 2025-08-05 | 0000950170-25-103041 |